Benzinga·2026-01-02 13:58Group 1 - As of January 2, 2026, two stocks in the health care sector are identified as potential warnings for momentum-focused investors [1] - The Relative Strength Index (RSI) is a key momentum indicator, with values above 70 indicating that a stock may be overbought [2] - Teva Pharmaceutical Industries Ltd has an RSI value of 71.6, with a recent stock price of $31.21, reflecting a 16% gain over the past month [6] - Exact Sciences Corp has an RSI value of 77.8, with a recent stock price of $101.56, reflecting a 7% gain over the past month [6] Group 2 - Teva's long-term issuer credit rating was upgraded to 'BB+' from 'BB' by S&P Global Ratings, with a stable outlook [6] - Abbott Laboratories agreed to acquire Exact Sciences for $105 per common share, totaling approximately $21 billion in equity value [6] - Exact Sciences has an estimated enterprise value of $23 billion following the acquisition announcement [6]